FGEN (FibroGen) Future Price to Earnings
Low revenue predictability due to failures of key drugs creates risks for FibroGen, Inc. (FGEN), as illustrated by the company's forward P/E ratio on a precise GURU.Markets chart, where the latest parameter is 0.00. Patents for fibrosis therapy provide a stable cash flow, while revenue currently relies on Chinese royalties and the search for new market niches.
Summary analytical data breakdowns for FibroGen Corporation (FGEN)
- current price and projected stock value:
- business market valuation indicators:
- balance sheet equity data:
- debt level and financial liquidity data:
- financial results and valuation multiples details:
FGEN - Company Net Income|Expected Profit FibroGen, Inc.|FGEN - Company Value to Net Income|Future Price to Earnings FibroGen Corp|FGEN - Price to Earnings Adjusted for Growth Rate|EV/EBITDA Multiple FibroGen Inc|FGEN - Operating profit before depreciation charges|Net earnings per share (EPS TTM) FibroGen|FGEN - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months fibrogen.com|FGEN - Earnings per share growth this year|Expected earnings per share growth for next year FibroGen, Inc.
Fundamental valuation:FibroGen
Forward P/E determines the stock price relative to expected net income, allowing for an assessment of the premium paid for future business growth. By analyzing the 12-month forward P/E of FibroGen, Inc. (FGEN), an investor can compare market expectations with the company's actual cash deficit, where restructuring and cost reductions become critical factors for achieving stated profitability targets.
Competitor analysis for FibroGen, Inc.
Projected Price to Earnings HLN (Haleon)|KVUE (Kenvue Inc) - Future Price to Earnings Multiple|Future Price to Earnings Verona Pharma Corp VRNA|Jyong Bio (MENS) - Projected Price to Earnings Ratio|LGND: Projected Price to Earnings|amneal.com - Market Cap to Future Earnings Ratio|PRGO: Forward P/E Multiple|Alvotech S.A. - Future Price to Earnings Multiple|LQDA (Liquidia Technologies) - Forward P/E Multiple|Projected Price to Earnings Ratio Galapagos Corp GLPG|Future Price to Earnings ANI Pharmaceuticals (ANIP)|MNKD (mannkindcorp.com) - Future Price to Earnings Multiple|Forward P/E Multiple AMPH (Amphastar Pharmaceuticals, Inc.)|PCRX (Pacira Pharmaceuticals) - Price to Expected Earnings Ratio|ARS Pharma - Forward P/E Multiple|Market Cap to Projected Earnings Theravance Corp TBPH|AQST: Forward P/E Multiple|SCPH (scPharmaceuticals) - Future Price to Earnings|Future Price to Earnings Tectonic Therapeutic Inc.|TNXP: Future Price to Earnings Multiple|Future Price to Earnings China SXT Pharmaceuticals (SXTC)|EPRX - Projected Price to Earnings Ratio|Forward P/E Multiple BHST (BioHarvest Sciences)|Forward Price to Earnings Multiple invizyne.com|Oramed Pharma - Forward P/E Multiple|Projected Price to Earnings Ratio Entera Bio Ltd.|MindWalk (HYFT) - Future Price to Earnings|Price to Future Earnings Ratio ABVC|Projected Price to Earnings CPIX|QNTM: Future Price to Earnings Multiple|Forward P/E Multiple TELO|Market Cap to Projected Earnings ranitherapeutics.com|Future Price to Earnings Synergy CHC SNYR|RLYB: Price to Future Earnings Ratio|Lexaria - Forward P/E Multiple|pulmatrix.com (PULM) - Projected Price to Earnings|PTHL (ftzy.com.cn) - Projected Price to Earnings|APM - Market Cap to Projected Earnings|LYRA (Lyra Therapeutics, Inc) - Forward P/E Multiple|Impact BioMedical, Inc. - Price to Expected Earnings Ratio|Forward P/E Multiple TNFA|cbdmd.com (YCBD) - Forward Price to Earnings Multiple|Forward P/E Multiple PRFX (PainReform)|Altamira Therapeutics Ltd (CYTO) - Projected Price to Earnings Ratio|LIPO - Future Price to Earnings|OPTN (OptiNose Corp) - Price to Future Earnings Ratio|Pieris Pharmaceuticals (PIRS) - Future Price to Earnings|Price to Expected Earnings Ratio PROC (procapsgroup.com)|PTPI (Petros Pharmaceuticals, Inc.) - Forward P/E Multiple|QLI: Future Price to Earnings Multiple|Forward P/E Multiple SLRN|Forward P/E Multiple TFF Pharmaceuticals, Inc (TFFP)
